Applied Radiology

Feb 15, 2023 | appliedradiology.com | Mary Beth Massat

Leslie Ferris Yerger’s story is one that, unfortunately, many women with dense breast tissue endure. In November 2017, Leslie was diagnosed with stage IV breast cancer, just two months after undergoing a mammogram and ultrasound exam, which both came back clear. “It was the absolute shock of my life,” said Yerger. “I didn't believe the diagnosis because it just didn’t add up.”Yerger’s cancer was discovered after a routine DEXA scan to measure her bone density.

Jan 17, 2023 | appliedradiology.com | McKenna Bryant

Please see link below for Important Safety Information for Vueway™In September 2022, Bracco Diagnostics Inc. announced US Food and Drug Administration (FDA) marketing approval for its new VUEWAY™ Gadopiclenol Injection. VUEWAY was approved under the FDA’s priority review process for products that represent significant improvements in safety or effectiveness.

Jan 17, 2023 | appliedradiology.com | McKenna Bryant

Please see below Important Safety Information for Elucirem™As radiology searches for ways to reduce patient exposure to gadolinium during magnetic resonance imaging (MRI) scans, a new tool has become available: Gadopiclenol injection, a new high-relaxivity contrast agent that will be marketed by Guerbet as Elucirem™. Gadolinium contrast is essential for enhancing the quality of MRI scans to make it easier for radiologists to identify pathology.

Jan 16, 2023 | appliedradiology.com | McKenna Bryant

Jan 16, 2023 | appliedradiology.com | McKenna Bryant